New No-Cost Course for Professionals in Stroke Centers with High-Volume of COVID-19

  • Coronavirus
  • COVID-19
  • Hemorrhagic stroke
  • Ischemic stroke
  • Stroke

The American Heart Association is offering an education course for healthcare professionals on stroke care with considerations for additional protocols and care practices that come with the COVID-19 pandemic. 

This course is made possible by support from the Leona B. and Harry M. Helmsley Charitable Trust. The Association and the Helmsley Trust share a desire to quickly deploy targeted training resources to give healthcare professionals the competence and confidence to appropriately treat individuals in critical care during the COVID-19 crisis.

The Stroke Care During the COVID-19 Pandemic course includes the following content:
•    Epidemiology of stroke during the COVID-19 pandemic based on global experience
•    Efects of COVID-19 on stroke presentation and management
•    Recommendations for systems of care and protocols for stroke during the COVID-19 pandemic
•    The general approach to optimizing acute and inpatient stroke care during the COVID-19 pandemic.

“A stroke is a very serious condition for patients, and the treatment options are often extremely time-sensitive,” said Ivette Motola, MD, MPH, FACEP, volunteer expert for the American Heart Association and assistant director for the University of Miami Gordon Center for Simulation and Innovation in Medical Education and medical director of its Advanced Stroke Life Support curricula. “These are challenging times and the rate of strokes has not diminished. Therefore, the goal of this course is to inform and empower health care professionals to safely apply evidence-based and guideline-directed care amidst a global pandemic.”

Neflamapimod Improves Cognition in Dementia With Lewy Bodies in Phase 2 Trial

Previous News Article

Nabiximols for Multiple Sclerosis-Associated Spasticity Phase 3 Studies in US Begin

Next News Article
This Month's Issue
Smart Business Great Medicine: Voice Assistance

James Geyer, MD, and Thomas Patton, MD

Blood Tests for Alzheimer Disease

Henrik Zetterberg, MD, PhD; Deborah O.T. Alawode, BSc; Ashvini Keshavan, MRCP, PhD; Antoinette O’Connor, MRCPI; Philip S. J. Weston, MRCP, PhD; Ross W. Paterson, MRCP, PhD; Amanda Heslegrave, PhD; Nick C. Fox, MD, FRCP, FMedSci; Michael P. Lunn, FRCP, PhD; and Jonathan M. Schott, MD, FRCP

Quantitative Structural MRI for Neurocognitive Disorders

Cyrus A. Raji, MD, PhD; Somayeh Meysami, MD; and Mario F. Mendez, MD, PhD